These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 38035921)

  • 41. Association between arterial stiffness and peripheral artery disease as measured by radial artery tonometry.
    Zahner GJ; Gruendl MA; Spaulding KA; Schaller MS; Hills NK; Gasper WJ; Grenon SM
    J Vasc Surg; 2017 Nov; 66(5):1518-1526. PubMed ID: 28756044
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Clinical and Liver Enzymes among the Patients with Metabolic Syndrome with or without Non Alcoholic Fatty Liver Disease attending a Tertiary Care Hospital.
    Mondal E; Karim MR; Begum A; Hassan K; Noor SM; Khan MM; Khan KH; Ashrafuzzaman SM
    Mymensingh Med J; 2023 Apr; 32(2):338-347. PubMed ID: 37002743
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Increased aortic stiffness and related factors in patients with peripheral arterial disease.
    Catalano M; Scandale G; Carzaniga G; Cinquini M; Minola M; Dimitrov G; Carotta M
    J Clin Hypertens (Greenwich); 2013 Oct; 15(10):712-6. PubMed ID: 24088278
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Liver and Cardiovascular Damage in Patients With Lean Nonalcoholic Fatty Liver Disease, and Association With Visceral Obesity.
    Fracanzani AL; Petta S; Lombardi R; Pisano G; Russello M; Consonni D; Di Marco V; Cammà C; Mensi L; Dongiovanni P; Valenti L; Craxì A; Fargion S
    Clin Gastroenterol Hepatol; 2017 Oct; 15(10):1604-1611.e1. PubMed ID: 28554682
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Association of Cardiovascular Risk Factors and Metabolic Syndrome with non-alcoholic and alcoholic fatty liver disease: a retrospective analysis.
    Han AL
    BMC Endocr Disord; 2021 May; 21(1):91. PubMed ID: 33933056
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Diagnostic Accuracy of Ankle-Brachial Pressure Index Compared with Doppler Arterial Waveforms for Detecting Peripheral Arterial Disease: A Systematic Review.
    Kashetsky N; Sachdeva M; Lu JD; Mufti A; Kim P; Bagit A; Sibbald RG
    Adv Skin Wound Care; 2022 Apr; 35(4):195-201. PubMed ID: 35311767
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A Study of Left Ventricular Dysfunction in Normotensive Non Diabetic Patients with Non Alcoholic Fatty Liver Disease.
    Tom NB; Harshvardhan L; Singhal M; Agarwal M; Mathur A; Jain T
    J Assoc Physicians India; 2022 Apr; 70(4):11-12. PubMed ID: 35443385
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Hepatic artery resistive index (HARI) and non-alcoholic fatty liver disease (NAFLD) fibrosis score in NAFLD patients: cut-off suggestive of non-alcoholic steatohepatitis (NASH) evolution.
    Tana C; Tana M; Rossi S; Silingardi M; Schiavone C
    J Ultrasound; 2016 Sep; 19(3):183-9. PubMed ID: 27635163
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Determinants of brachial-ankle pulse wave velocity and carotid-femoral pulse wave velocity in healthy Koreans.
    Jang SY; Ju EY; Huh EH; Kim JH; Kim DK
    J Korean Med Sci; 2014 Jun; 29(6):798-804. PubMed ID: 24932081
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The Association Between Cholecystectomy, Metabolic Syndrome, and Nonalcoholic Fatty Liver Disease: A Population-Based Study.
    Latenstein CSS; Alferink LJM; Darwish Murad S; Drenth JPH; van Laarhoven CJHM; de Reuver PR
    Clin Transl Gastroenterol; 2020 Apr; 11(4):e00170. PubMed ID: 32352682
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Arterial stiffness and peripheral arterial disease in patients with systemic lupus erythematosus.
    Tziomalos K; Gkougkourelas I; Sarantopoulos A; Bekiari E; Makri E; Raptis N; Tselios K; Pantoura M; Hatzitolios AI; Boura P
    Rheumatol Int; 2017 Feb; 37(2):293-298. PubMed ID: 27873008
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Association of metabolic syndrome and its components with arterial stiffness in Caucasian subjects of the MARK study: a cross-sectional trial.
    Gomez-Sanchez L; Garcia-Ortiz L; Patino-Alonso MC; Recio-Rodriguez JI; Fernando R; Marti R; Agudo-Conde C; Rodriguez-Sanchez E; Maderuelo-Fernandez JA; Ramos R; Gomez-Marcos MA;
    Cardiovasc Diabetol; 2016 Oct; 15(1):148. PubMed ID: 27776526
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Peripheral artery disease and all-cause and cardiovascular mortality in patients with NAFLD.
    Ciardullo S; Bianconi E; Cannistraci R; Parmeggiani P; Marone EM; Perseghin G
    J Endocrinol Invest; 2022 Aug; 45(8):1547-1553. PubMed ID: 35364761
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Advanced glycation end-products, measured as skin autofluorescence, associate with vascular stiffness in diabetic, pre-diabetic and normoglycemic individuals: a cross-sectional study.
    Birukov A; Cuadrat R; Polemiti E; Eichelmann F; Schulze MB
    Cardiovasc Diabetol; 2021 Jun; 20(1):110. PubMed ID: 34176469
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Impact of brachial-ankle pulse wave velocity and ankle-brachial blood pressure index on mortality in hemodialysis patients.
    Kitahara T; Ono K; Tsuchida A; Kawai H; Shinohara M; Ishii Y; Koyanagi H; Noguchi T; Matsumoto T; Sekihara T; Watanabe Y; Kanai H; Ishida H; Nojima Y
    Am J Kidney Dis; 2005 Oct; 46(4):688-96. PubMed ID: 16183424
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effect of Low (5 mg) vs. High (20-40 mg) Rosuvastatin Dose on 24h Arterial Stiffness, Central Haemodynamics, and Non-Alcoholic Fatty Liver Disease in Patients with Optimally Controlled Arterial Hypertension.
    Mitsiou E; Boutari C; Kotsis V; Georgianou E; Doumas M; Karagiannis A; Athyros VG
    Curr Vasc Pharmacol; 2018; 16(4):393-400. PubMed ID: 28669329
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Ankle-brachial index screening for peripheral artery disease in high cardiovascular risk patients. Prospective observational study of 370 asymptomatic patients at high cardiovascular risk].
    Rada C; Oummou S; Merzouk F; Amarir B; Boussabnia G; Bougrini H; Benzaroual D; Elkarimi S; Elhattaoui M
    J Mal Vasc; 2016 Dec; 41(6):353-357. PubMed ID: 27865565
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Factors influencing subclinical atherosclerosis in patients with biopsy-proven nonalcoholic fatty liver disease.
    Arai T; Atsukawa M; Tsubota A; Kawano T; Koeda M; Yoshida Y; Tanabe T; Okubo T; Hayama K; Iwashita A; Itokawa N; Kondo C; Kaneko K; Kawamoto C; Hatori T; Emoto N; Iio E; Tanaka Y; Iwakiri K
    PLoS One; 2019; 14(11):e0224184. PubMed ID: 31721770
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Central blood pressure and pulse wave velocity: relationship to target organ damage and cardiovascular morbidity-mortality in diabetic patients or metabolic syndrome. An observational prospective study. LOD-DIABETES study protocol.
    Gómez-Marcos MA; Recio-Rodríguez JI; Rodríguez-Sánchez E; Castaño-Sánchez Y; de Cabo-Laso A; Sánchez-Salgado B; Rodríguez-Martín C; Castaño-Sánchez C; Gómez-Sánchez L; García-Ortiz L
    BMC Public Health; 2010 Mar; 10():143. PubMed ID: 20298558
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Arterial stiffness in patients with non-alcoholic fatty liver disease is related to fibrosis stage and epicardial adipose tissue thickness.
    Sunbul M; Agirbasli M; Durmus E; Kivrak T; Akin H; Aydin Y; Ergelen R; Yilmaz Y
    Atherosclerosis; 2014 Dec; 237(2):490-3. PubMed ID: 25463079
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.